Orchestra BioMed Holdings, Inc. (OBIO): R&D Expense
$58.19M
Year ended 2025-12-31
$63.22M
Trailing 12 months to 2026-06-30
+38.4%
3-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $58.19M | +35.9% | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | $42.80M | +26.6% | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | $33.82M | +54.1% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $21.95M | n/a | 2024-03-27, From 2022-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | 2025-12-31 | $58.19M | +35.9% |
| ClearPoint Neuro, Inc. (CLPT) | 2025-12-31 | $13.90M | +12.1% |
| Retractable Technologies Inc (RVP) | 2025-12-31 | $675.6K | +0.2% |
| Utah Medical Products Inc (UTMD) | 2025-12-31 | $668.0K | -17.8% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $642.0K | -5.0% |
| Sensus Healthcare, Inc. (SRTS) | 2025-12-31 | $7.78M | +84.5% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $4.39M | -16.6% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $3.69M | +47.9% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $1.35M | +101.0% |
Compare OBIO, CLPT, RVP, UTMD side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗